Thrombin functions during tissue factor-induced blood coagulation

被引:306
作者
Brummel, KE [1 ]
Paradis, SG [1 ]
Butenas, S [1 ]
Mann, KG [1 ]
机构
[1] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA
关键词
D O I
10.1182/blood.V100.1.148
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tissue factor-induced blood coagulation was studied in 20 individuals, for varying periods of time during 54 months, in contact pathway-inhibited whole blood at 37degreesC and evaluated in terms of the activation of various substrates. After quenching over time with inhibitors, the soluble phases were analyzed for thrombin-antithrombin III (TAT) complex formation, prothrombin fragments, platelet activation (osteonectin release), factor Va generation, fibrinopeptide (FP) A and FPB release, and factor XIII activation. TAT complex formation, for 35 experiments, showed an initiation phase (up to 4.6+/-0.6 minutes) in which thrombin was generated at an average rate of 0.93+/-0.3 nM/min catalyzed by about 1.3 pM prothrombinase yielding approximately 26 nM thrombin. During a subsequent propagation phase, thrombin was generated at a rate of 83.9+/-3.8 nM/min by about 120 pM prothrombinase, reaching ultimate levels of 851+/-53 nM. Clot time, determined subjectively, occurred at 4.7+/-0.2 minutes and correlated with the inception of the propagation phase. The thrombin concentrations associated with the transitions to rapid product formation are 510+/-180 pM for platelet activation (1.9+/-0.2 minutes), 840+/-280 pM for factor XIII activation and factor Va generation (2.2+/-0.6 minutes), 1.3+/-0.4 nM for FPA release (2.5+/-0.7 minutes), 1.7+/-0.5 nM for FPB release and prethrombin 2 (2.8+/-0.8 minutes), 7.0+/-2.2 nM for thrombin B chain (3.6+/-0.2 minutes), and 26+/-6.2 nM for the propagation phase of TAT formation (4.6+/-0.6 minutes). These results illustrate that the initial activation of thrombin substrates occurs during the initiation phase at less than 2 nM thrombin (0.2%). Most thrombin (96%) is formed well after clotting occurs.
引用
收藏
页码:148 / 152
页数:5
相关论文
共 23 条
[1]   PURIFICATION AND CHARACTERIZATION OF TAFI, A THROMBIN-ACTIVABLE FIBRINOLYSIS INHIBITOR [J].
BAJZAR, L ;
MANUEL, R ;
NESHEIM, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (24) :14477-14484
[2]   SIMPLE METHOD FOR PREPARATION OF HOMOGENEOUS PHOSPHOLIPID VESICLES [J].
BARENHOLZ, Y ;
GIBBES, D ;
LITMAN, BJ ;
GOLL, J ;
THOMPSON, TE ;
CARLSON, FD .
BIOCHEMISTRY, 1977, 16 (12) :2806-2810
[3]   An integrated study of fibrinogen during blood coagulation [J].
Brummel, KE ;
Butenas, S ;
Mann, KG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (32) :22862-22870
[4]   Blood coagulation in hemophilia A and hemophilia C [J].
Cawthern, KM ;
van't Veer, C ;
Lock, JB ;
DiLorenzo, ME ;
Branda, RF ;
Mann, KG .
BLOOD, 1998, 91 (12) :4581-4592
[5]   ACTIONS OF THROMBIN AND OTHER COAGULANT AND PROTEOLYTIC ENZYMES ON BLOOD PLATELETS [J].
DAVEY, MG ;
LUSCHER, EF .
NATURE, 1967, 216 (5118) :857-&
[6]  
DOYLE MF, 1990, J BIOL CHEM, V265, P10693
[7]   SUBUNIT STRUCTURE OF THROMBIN-ACTIVATED HUMAN FACTOR-VIIIA [J].
FAY, PJ .
BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 952 (02) :181-190
[8]  
FOSTER WB, 1983, BLOOD, V61, P1060
[9]   FACTOR-XI ACTIVATION IN A REVISED MODEL OF BLOOD-COAGULATION [J].
GAILANI, D ;
BROZE, GJ .
SCIENCE, 1991, 253 (5022) :909-912
[10]  
HIGGINS DL, 1983, J BIOL CHEM, V258, P9276